Sanofi Menactra Meningococcal Vaccine from Canada
Menactra protects against Neisseria meningitidis serogroups A, C, Y, W-135 via polysaccharide-protein conjugates. Its retail syringe packaging for measured doses classifies it under HTS 3002.15.00.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Verify conjugate integrity; include protein/polysaccharide ratio certificates
• EUAs for emergency import; track pediatric vs adult formulations